DNA Ploidy Analysis System
The DNA Ploidy Analysis System combines with SurePath™ liquid-based cytology to create a dual-modality cervical cancer screening solution — one preparation, two tests. Automated quantitative DNA ploidy analysis detects chromosomal abnormalities at the molecular level, identifying occult lesions that conventional cytology may miss, and raising CIN2+ detection sensitivity to 96.9%.
View Details